BioSpace News Archive

Business

RadioMedix Selected for National Cancer Institute’s Investor Initiatives and Presentation at BIO Investor Forum

t is a unique opportunity to present pipeline of RadioMedix products and offer clinical and R&D services to biopharma experts and investors.

October 17, 2017

·

2 min read

Drug Development

AntriaBio Announces Selection of Lead Oral Plasma Kallikrein Inhibitor Candidates for the Treatment of Diabetic Retinopathy, Diabetic Macular Edema and Hereditary Angioedema

The two preclinical programs are AB402 for vision-threatening eye complications of diabetes including Diabetic Retinopathy and Diabetic Macular Edema, and AB602, which is being developed to treat Hereditary Angioedema.

October 17, 2017

·

5 min read

Genetown

WuXi NextCODE At ASHG: Population Genomics, Unleashing Cancer Data, Diagnosing Rare Disease, The Internet Of DNA

WuXi NextCODE, the global standard platform for genomic data, invites attendees at the American Society of Human Genetics annual meeting being held this week in Orlando to visit booth #1031.

October 17, 2017

·

2 min read

Business

Intricon To Announce 2017 Third-Quarter Results On Monday, November 6

IntriCon Corporation announced that it will release its 2017 third-quarter results on Monday, November 6, 2017, at market close.

October 17, 2017

·

1 min read

Business

Bovie Medical Corporation to Release Third Quarter 2017 Financial Results on November 2, 2017

Bovie Medical announced that financial results for the third quarter of 2017 will be released after the market closes on Thursday, November 2.

October 17, 2017

·

2 min read

Biotech Bay

Biotime, Inc. Announces Closing Of Public Offering And Underwriters’ Full Exercise Of Over-Allotment Option

BioTime, Inc. announced the closing of its previously announced public offering of 9,615,385 shares of common stock, including 1,442,308 shares sold pursuant to the underwriters’ exercise in full of their option to purchase additional shares.

October 17, 2017

·

3 min read

Biotech Beach

As Patent Expires, AHF Calls on Gilead for 90% Price Reduction on Tenofovir-based Drugs, Including Truvada

AIDS Healthcare Foundation (AHF), the largest global AIDS organization and a vocal critic of runaway drug pricing and drug profiteering, today called on Gilead Sciences, Inc. to reduce the price of its tenofovir-based drug regimens-including Truvada-by as much as 90%.

October 17, 2017

·

5 min read

Business

Catapult Ventures Appoints Kevin D’Silva As Venture Partner

Catapult Ventures has announced that Kevin D’Silva has been appointed as a Venture Partner with its GM&C Life Sciences Fund.

October 17, 2017

·

3 min read

Drug Development

iSTAR Medical Completes Enrollment Of First-In-Human Migs Trial

iSTAR Medical announced today the completion of enrollment in their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device.

October 17, 2017

·

2 min read

Desktop Genetics Introduces New Series Of Customizable CRISPR Libraries

Desktop Genetics Ltd announced the launch of its DESKGEN Series CRISPR Libraries to support gene editing efforts in academic and biopharma settings.

October 17, 2017

·

3 min read